lonza 5 odt olanzapine 5mg orodispersible tablet blister pack
medis pharma pty ltd - olanzapine, quantity: 5 mg - tablet, orally disintegrating - excipient ingredients: microcrystalline cellulose; mannitol; pregelatinised maize starch; crospovidone; sodium lauryl sulfate; aspartame; colloidal anhydrous silica; magnesium stearate; guar gum - treatment of schizophrenia and related psychoses. short-term treatment, alone or in combination with lithium or valproate, of acute manic episodes associated with bipolar i disorder. preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.
lonza 10 olanzapine 10mg tablet blister pack
medis pharma pty ltd - olanzapine, quantity: 10 mg - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; crospovidone; magnesium stearate; hyprolose; titanium dioxide; hypromellose; macrogol 400 - treatment of schizophrenia and related psychoses. short-term treatment, alone or in combination with lithium or valproate, of acute manic episodes associated with bipolar i disorder. preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.
lonza 7.5 olanzapine 7.5mg tablet blister pack
medis pharma pty ltd - olanzapine, quantity: 7.5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; crospovidone; magnesium stearate; hyprolose; titanium dioxide; hypromellose; macrogol 400 - treatment of schizophrenia and related psychoses. short-term treatment, alone or in combination with lithium or valproate, of acute manic episodes associated with bipolar i disorder. preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.
lonza 5 olanzapine 5mg tablet blister pack
medis pharma pty ltd - olanzapine, quantity: 5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; crospovidone; magnesium stearate; hyprolose; titanium dioxide; hypromellose; macrogol 400 - treatment of schizophrenia and related psychoses. short-term treatment, alone or in combination with lithium or valproate, of acute manic episodes associated with bipolar i disorder. preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.
lonza 2.5 olanzapine 2.5mg tablet blister pack
medis pharma pty ltd - olanzapine, quantity: 2.5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; crospovidone; magnesium stearate; hyprolose; titanium dioxide; hypromellose; macrogol 4000; sodium citrate dihydrate - treatment of schizophrenia and related psychoses. short-term treatment, alone or in combination with lithium or valproate, of acute manic episodes associated with bipolar i disorder. preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.
liba 10 000
lonza nz limited - indolebutyric acid - indolebutyric acid 10 g/litre - plant growth regulator
chlorotek
lonza nz limited - chlorothalonil - chlorothalonil 500 g/litre - fungicide
tag
lonza nz limited - terbuthylazine; amitrole; glyphosate - terbuthylazine 375 g/litre; amitrole 60 g/litre; glyphosate 100 g/litre - herbicide
victory
lonza nz limited - triclopyr - triclopyr 600 g/litre - herbicide
prostar
lonza nz limited - myclobutanil - myclobutanil 125 g/litre - fungicide